6NAD | pdb_00006nad

Identification and biological evaluation of tertiary ALCOHOL-based inverse agonists of RORgt


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.90 Å
  • R-Value Free: 
    0.234 (Depositor), 0.240 (DCC) 
  • R-Value Work: 
    0.176 (Depositor), 0.190 (DCC) 
  • R-Value Observed: 
    0.182 (Depositor) 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 

Created with Raphaël 2.3.0Worse 01 BetterLigand structure goodness of fit to experimental dataBest fitted KHYClick on this verticalbar to view details

This is version 1.2 of the entry. See complete history


Literature

3-Substituted Quinolines as ROR gamma t Inverse Agonists.

Tanis, V.M.Venkatesan, H.Cummings, M.D.Albers, M.Kent Barbay, J.Herman, K.Kummer, D.A.Milligan, C.Nelen, M.I.Nishimura, R.Schlueter, T.Scott, B.Spurlino, J.Wolin, R.Woods, C.Xue, X.Edwards, J.P.Fourie, A.M.Leonard, K.

(2019) Bioorg Med Chem Lett 29: 1463-1470

  • DOI: https://doi.org/10.1016/j.bmcl.2019.04.021
  • Primary Citation of Related Structures:  
    6NAD

  • PubMed Abstract: 

    We have previously reported the syntheses of a series of 3,6-disubstituted quinolines as modulators of the retinoic acid receptor-related orphan receptor gamma t (RORγt). These molecules are potent binders but are high molecular weight and they exhibited poor solubility at pH 2 and pH 7. This manuscript details our efforts at improving physical chemical properties for this series of compounds by increasing the diversity at the 3-position (i.e. introducing heteroatoms and lowering the molecular weight). These efforts have led to molecules which are potent binders with improved solubility.


  • Organizational Affiliation

    Discovery Product Development and Supply, Janssen Research and Development, 3210 Merryfield Row, San Diego, CA 92121, United States. Electronic address: vtanis@its.jnj.com.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Nuclear receptor ROR-gamma
A, B
243Homo sapiensMutation(s): 0 
Gene Names: RORCNR1F3RORGRZRG
UniProt & NIH Common Fund Data Resources
Find proteins for P51449 (Homo sapiens)
Explore P51449 
Go to UniProtKB:  P51449
PHAROS:  P51449
GTEx:  ENSG00000143365 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP51449
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
KHY
Query on KHY

Download Ideal Coordinates CCD File 
C [auth A],
D [auth B]
(S)-(4-chloro-2-methoxy-3-{[4-(trifluoromethyl)piperidin-1-yl]methyl}quinolin-6-yl)(1,2-dimethyl-1H-imidazol-5-yl)[2-(trifluoromethyl)pyridin-4-yl]methanol
C29 H28 Cl F6 N5 O2
SXCAASBRTBWENF-MHZLTWQESA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
KHY BindingDB:  6NAD Kd: min: 0.47, max: 0.5 (nM) from 2 assay(s)
IC50: 14 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.90 Å
  • R-Value Free:  0.234 (Depositor), 0.240 (DCC) 
  • R-Value Work:  0.176 (Depositor), 0.190 (DCC) 
  • R-Value Observed: 0.182 (Depositor) 
Space Group: P 61
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 96.742α = 90
b = 96.742β = 90
c = 127.711γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-2000data reduction
HKL-2000data scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 

Created with Raphaël 2.3.0Worse 01 BetterLigand structure goodness of fit to experimental dataBest fitted KHYClick on this verticalbar to view details

Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2019-05-08
    Type: Initial release
  • Version 1.1: 2019-05-15
    Changes: Data collection, Database references
  • Version 1.2: 2024-03-13
    Changes: Data collection, Database references